Intestinal transport of scutellarein and scutellarin and first-pass metabolism by UDP-glucuronosyltransferase-mediated glucuronidation of scutellarein and hydrolysis of scutellarin

References

• Che QM, Chen Y, Pan LY, He H. (2006). Scutellarein’s pharmacokinetics in rat. Chin J New Drug 15:1557–1561.
   Google Scholar
• Che QM, Pan LY, Chen Y, He H. (2007). Study on pharmacokinetics of scutellarein in rats. Chin J Pharm 42:1418–1421.
   Google Scholar
• Chen XX, He B. (1998). Effects of breviscapine on the changes in antioxidant enzyme activity induced by cerebral ischemia reperfusion in rats. J Chi Pharm Sci 7:91–93.
   Google Scholar
• Chen X, Cui L, Duan X, Ma B, Zhong D. (2006). Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration. Drug Metab Dispos 34:1345–1352.
   PubMed Web of Science ®Google Scholar
• Chen YK, Xie SG, Chen SQ, Zeng S. (2008). Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9. Biochem Pharmacol 76:416–425.
   PubMed Web of Science ®Google Scholar
• Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA. (2001). The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 33:273–297.
   PubMed Web of Science ®Google Scholar
• Ge QH, Zhou Z, Zhi XJ, Ma LL, Chen XH. (2003). Pharmacokinetics and absolute bioavailability of breviscapine in beagle dogs. Chin J Pharm 34:618–632.
   Google Scholar
• Hao X, Cheng G, Yu JE, He Y, An F, Sun J, Cui FD. (2005). Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats. Pharmazie 60:477–478.
   PubMed Web of Science ®Google Scholar
• Huang JM, Li N, Yu YQ, Weng WY, Huang XB. (2006). Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC. J Pharm Biomed Anal 40:465–471.
   PubMed Web of Science ®Google Scholar
• Huang JM, Weng WY, Huang XB, Ji YH, Chen E. (2005). Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats. Eur J Drug Metab Pharmacokinet 30:165–170.
   PubMed Web of Science ®Google Scholar
• Ju WZ, Chu JH, Tan RX, Xiong NN. (2006). Study on metabolites of scutellarin in gastrointestinal tract by UPLC-MS-MS method. Chin J Clin Pharmacol Ther 11:292–295.
   Google Scholar
• Ju WZ, Zhang J, Tan HS, Jiang M, Chen M, Xiong NN. (2005). Determination of scutellarin in human plasma by LC-MS method and its clinical pharmacokinetics in Chinese healthy volunteers. Chin J Clin Pharmacol Ther 10:298–301.
   Google Scholar
• Laurence A, Jing X, Joanna ML, Brian B, Jacques M, Anna RP. (2003). Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7. Arch Biochem Biophys 411:251–261.
   PubMedGoogle Scholar
• Liu H, Yang XL, Wang Y, Tang XQ, Jiang DY, Xu HB. (2003). Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes. Acta Pharmacol Sin 24:1113–1117.
   PubMed Web of Science ®Google Scholar
• Liu Q, Shi Y, Wang Y, Lu J, Cong W, Luo G, Wang Y. (2009). Metabolism profile of scutellarin in urine following oral administration to rats by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry. Talanta 80:84–91.
   PubMed Web of Science ®Google Scholar
• Louise EP, Kathryn MA, Elaine M, Dianne F. (2008). Glucuronidation of the soyabean isoflavones genistein and daidzein by human liver is related to levels of UGT1A1 and UGT1A9 activity and alters isoflavone response in the MCF-7 human breast cancer cell line. J Nutr Biochem 19:739–745.
   PubMedGoogle Scholar
• O’Leary KA, Day AJ, Needs PW, Sly WS, O’Brien NM, Williamson G. (2001). Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett 503:103–106.
   PubMed Web of Science ®Google Scholar
• Owens IS, Basu NK, Banerjee R. (2005). UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Meth Enzymol 400:1–22.
   PubMed Web of Science ®Google Scholar
• Tukey RH, Strassburg CP. (2000). Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581–616.
   PubMed Web of Science ®Google Scholar
• Yu L, Lu S, Lin Y, Zeng S. (2007). Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases. Biochem Pharmacol 73:1842–1851.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li XS, Zhang WD. (2002). The advance in studies on chemical component and pharmacology of Erigeron breviscapus. J Pharm Pract 20:103–107.
   Google Scholar
• Zhang L, Lin G, Zuo Z. (2006). Position preference on glucuronidation of mono-hydroxylflavones in human intestine. Life Sci 78:2772–2780.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin G, Zuo Z. (2007). Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein. Pharm Res 24:81–89.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zheng Y, Chow MS, Zuo Z. (2004). Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int J Pharm 287:1–12.
   PubMed Web of Science ®Google Scholar
• Zhou J, Lei H, Chen Y, Li F, Ma C. (2002). Ventricular remodeling by Scutellarein treatment in spontaneously hypertensive rats. Chin Med J 115:375–377.
   PubMedGoogle Scholar
• Zhou Q, Zheng Z, Xia B, Tang L, Lv C, Liu W, Liu Z, Hu M. (2010). Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes. Pharm Res 27:1568–1583.
   PubMed Web of Science ®Google Scholar
• Zhu BH, Guan YY, He H, Lin MJ. (2000). Effects of Scutellarein on diabetic rat aorta. Acta Pharmacol Sin 21:353–356.
   PubMed Web of Science ®Google Scholar